MPV17 and myelodysplastic syndrome: Most remarkably, the ability of OA (considered in the past vitamin B13) to increase mtDNA content in mpv17 KO mutants, the availability of this nutrient in dairy products and its current use as a food supplement open new opportunities in the treatment of MPV17-related MDS, to date a disease with poor prognosis and no cure yet available.